Literature DB >> 33684639

The effects of core stabilization exercise program in obese people awaiting bariatric surgery: A randomized controlled study.

Nilay Arman1, Gulfidan Tokgoz2, Hakan Seyit3, Mehmet Karabulut3.   

Abstract

OBJECTIVE: The aim of this study was the effects of the core stabilization exercise program (CSEP) and physical activity counseling on functional capacity, physical fitness, physical activity, fatigue and quality of life (QoL) in obese people awaiting bariatric surgery.
METHODS: Twenty-one patients were divided into two groups: an exercise group (n = 10) and a control group (n = 11). Both groups received physical activity counseling, but the exercise group also performed an 8-week CSEP. Functional capacity, physical fitness, physical activity, fatigue and QoL were assessed at baseline and after 8 weeks.
RESULTS: After eight weeks, results showed significant improvements in all parameters except for body composition for the exercise group, comparing to the control group (effect size = 0.40-0.87, p < 0.05).
CONCLUSIONS: Implementing an 8-week adding CSEP to physical activity counseling provided significant improvements in functional capacity, physical fitness, physical activity, fatigue and QoL compared to physical activity counseling in obese people awaiting bariatric surgery.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Exercise; Morbid obesity; Physical activity; Physical fitness; Quality of life

Year:  2021        PMID: 33684639     DOI: 10.1016/j.ctcp.2021.101342

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  1 in total

Review 1.  Effects of Supervised Physical Exercise as Prehabilitation on Body Composition, Functional Capacity and Quality of Life in Bariatric Surgery Candidates: A Systematic Review and Meta-Analysis.

Authors:  Andrea Herrera-Santelices; Graciela Argüello-Florencio; Greice Westphal; Nelson Nardo Junior; Antonio Roberto Zamunér
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.